Core Laboratories (NYSE:CLB) CEO Lawrence Bruno Buys 5,000 Shares of Stock

Core Laboratories Inc. (NYSE:CLB) CEO Lawrence Bruno purchased 5,000 shares of Core Laboratories stock in a transaction dated Friday, July 31st. The stock was acquired at an average price of $10.78 per share, for a total transaction of $53,900.00. Following the completion of the acquisition, the chief executive officer owned 262,438 shares of the company’s stock, valued at approximately $2,829,081.64. This trade represents a 1.94% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Core Laboratories Trading Up 3.0%

CLB traded up $0.32 during trading hours on Tuesday, reaching $11.03. 125,829 shares of the company’s stock traded hands, compared to its average volume of 591,485. The firm has a 50-day moving average price of $11.94 and a 200 day moving average price of $15.15. The firm has a market capitalization of $508.63 million, a PE ratio of 19.79, a PEG ratio of 2.57 and a beta of 1.00. The company has a quick ratio of 1.55, a current ratio of 2.12 and a debt-to-equity ratio of 0.41. Core Laboratories Inc. has a 52-week low of $9.72 and a 52-week high of $20.36.

Core Laboratories (NYSE:CLB) last released its earnings results on Wednesday, July 29th. The oil and gas company reported $0.11 earnings per share for the quarter, topping the consensus estimate of $0.09 by $0.02. The business had revenue of $124.61 million during the quarter, compared to the consensus estimate of $126.26 million. Core Laboratories had a return on equity of 10.03% and a net margin of 5.10%.The business’s revenue for the quarter was down 4.3% compared to the same quarter last year. During the same period last year, the company earned $0.19 earnings per share. Core Laboratories has set its Q3 2026 guidance at 0.120-0.200 EPS. As a group, sell-side analysts predict that Core Laboratories Inc. will post 0.53 EPS for the current fiscal year.

Core Laboratories Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, August 31st. Shareholders of record on Monday, August 10th will be given a $0.01 dividend. This represents a $0.04 annualized dividend and a yield of 0.4%. The ex-dividend date of this dividend is Monday, August 10th. Core Laboratories’s payout ratio is 7.14%.

Analysts Set New Price Targets

A number of equities analysts have recently commented on the stock. Wall Street Zen raised shares of Core Laboratories from a “sell” rating to a “hold” rating in a research report on Saturday. Weiss Ratings downgraded Core Laboratories from a “hold (c-)” rating to a “sell (d+)” rating in a report on Wednesday, June 24th. One analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Reduce”.

Institutional Trading of Core Laboratories

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Summit Securities Group LLC purchased a new position in Core Laboratories during the first quarter worth approximately $31,000. Aster Capital Management DIFC Ltd acquired a new stake in shares of Core Laboratories during the fourth quarter worth about $34,000. CWM LLC increased its holdings in Core Laboratories by 36.1% during the 4th quarter. CWM LLC now owns 2,516 shares of the oil and gas company’s stock worth $40,000 after purchasing an additional 668 shares during the period. Quarry LP raised its holdings in shares of Core Laboratories by 118.1% in the 3rd quarter. Quarry LP now owns 2,953 shares of the oil and gas company’s stock valued at $36,000 after purchasing an additional 1,599 shares in the last quarter. Finally, Hantz Financial Services Inc. increased its holdings in shares of Core Laboratories by 124.7% in the 4th quarter. Hantz Financial Services Inc. now owns 3,177 shares of the oil and gas company’s stock valued at $51,000 after acquiring an additional 1,763 shares during the last quarter. Institutional investors and hedge funds own 97.81% of the company’s stock.

About Core Laboratories

Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets.

The company’s portfolio spans two primary service lines: reservoir description and production enhancement.